Offer - Urjas Oil for just ₹ 1 X
Levocetirizine + Montelukast + Ambroxol is an allopathic medicine The correct dosage of Levocetirizine + Montelukast + Ambroxol depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Levocetirizine + Montelukast + Ambroxol is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Levocetirizine + Montelukast + Ambroxol is used -
Severe
Moderate
Mild
Common
Is the use of Levocetirizine + Montelukast + Ambroxol safe for pregnant women?
Pregnant women may get severe side effects after taking Levocetirizine + Montelukast + Ambroxol. If you are pregnant, do not take Levocetirizine + Montelukast + Ambroxol without a doctor's advice.
Is the use of Levocetirizine + Montelukast + Ambroxol safe during breastfeeding?
Levocetirizine + Montelukast + Ambroxol may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Levocetirizine + Montelukast + Ambroxol on the Kidneys?
Levocetirizine + Montelukast + Ambroxol has very mild side effects on the kidneys.
What is the effect of Levocetirizine + Montelukast + Ambroxol on the Liver?
Levocetirizine + Montelukast + Ambroxol has very mild side effects on the liver.
What is the effect of Levocetirizine + Montelukast + Ambroxol on the Heart?
Very few cases of side effects of Levocetirizine + Montelukast + Ambroxol on the heart have been reported.
Levocetirizine + Montelukast + Ambroxol should not be taken with following medicines due to severe side effects it may cause to patients -
Life Threatening
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Levocetirizine + Montelukast + Ambroxol unless your doctor advises you to do so -
Is this Levocetirizine + Montelukast + Ambroxol habit forming or addictive?
Levocetirizine + Montelukast + Ambroxol is not addictive in nature.
Interaction between Food and Levocetirizine + Montelukast + Ambroxol
Information is not available on the interaction of any foods with Levocetirizine + Montelukast + Ambroxol, due to a lack of research on this.
Interaction between Alcohol and Levocetirizine + Montelukast + Ambroxol
Due to lack of research, there is no information about the side effects of taking Levocetirizine + Montelukast + Ambroxol with alcohol.
No, Levocetirizine + Montelukast + Ambroxol is not a decongestant. It is an antihistamine, used to relieve symptoms of allergic rhinitis, urticaria, runny nose, itching eyes/nose, and sneezing.
Absorption of Levocetirizine + Montelukast + Ambroxol is not affected by food and hence can be taken with or without food. Preferably it should be taken in the evening. However, you are recommended to take it as per the doctor's instructions.
Yes, Levocetirizine + Montelukast + Ambroxol can be taken with paracetamol. No harmful drug interaction has been reported between them. However, if you feel any unpleasant effects then consult your doctor.
Levocetirizine + Montelukast + Ambroxol is a prescription drug so do not take it without a consulting doctor. It can be harmful for the patient to take this medicine without a doctor's recommendation.
Yes, Levocetirizine + Montelukast + Ambroxol can be taken with montelukast. As per clinical studies, no harmful interaction has been reported after taking them. However, do not take it without doctors advise. A fixed-dose combination of [Medicinie] and montelukast is available in the market which is used in the treatment of respiratory tract inflammation.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xyzal® (levocetirizine dihydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 164,167
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 873-874
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 228
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Singulair® (montelukast sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lukair® (montelukast sodium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 219